Article
Conserved structural and functional control of N-methyl-D-aspartate receptor gating by transmembrane domain M3.
Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, Atlanta, Georgia 30322-3090, USA.
Journal of Biological Chemistry (impact factor:
4.77).
09/2005;
280(33):29708-16.
DOI:10.1074/jbc.M414215200
pp.29708-16
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Mechanism of differential control of NMDA receptor activity by NR2 subunits.
[show abstract] [hide abstract]
ABSTRACT: N-methyl-d-aspartate (NMDA) receptors (NMDARs) are a major class of excitatory neurotransmitter receptors in the central nervous system. They form glutamate-gated ion channels that are highly permeable to calcium and mediate activity-dependent synaptic plasticity. NMDAR dysfunction is implicated in multiple brain disorders, including stroke, chronic pain and schizophrenia. NMDARs exist as multiple subtypes with distinct pharmacological and biophysical properties that are largely determined by the type of NR2 subunit (NR2A to NR2D) incorporated in the heteromeric NR1/NR2 complex. A fundamental difference between NMDAR subtypes is their channel maximal open probability (P(o)), which spans a 50-fold range from about 0.5 for NR2A-containing receptors to about 0.01 for receptors containing NR2C and NR2D; NR2B-containing receptors have an intermediate value (about 0.1). These differences in P(o) confer unique charge transfer capacities and signalling properties on each receptor subtype. The molecular basis for this profound difference in activity between NMDAR subtypes is unknown. Here we show that the subunit-specific gating of NMDARs is controlled by the region formed by the NR2 amino-terminal domain (NTD), an extracellular clamshell-like domain previously shown to bind allosteric inhibitors, and the short linker connecting the NTD to the agonist-binding domain (ABD). The subtype specificity of NMDAR P(o) largely reflects differences in the spontaneous (ligand-independent) equilibrium between open-cleft and closed-cleft conformations of the NR2-NTD. This NTD-driven gating control also affects pharmacological properties by setting the sensitivity to the endogenous inhibitors zinc and protons. Our results provide a proof of concept for a drug-based bidirectional control of NMDAR activity by using molecules acting either as NR2-NTD 'closers' or 'openers' promoting receptor inhibition or potentiation, respectively.Nature 05/2009; 459(7247):703-7. · 36.28 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
7-Cl-kynurenic acid
allosteric modulators
channel conductance
channel gating
channel open probability
competitive antagonists D-2-amino-5-phosphonovaleric acid
extracellular protons
glutamate potency
glutamate receptor ion channel gating
Modified channels
molecular events
MT-SEA-modified receptors
NMDA receptors
partial sensitivity
previous measurements
single-channel open time
stimulate agonist unbinding
structural determinant
SYTANLAAF motif
transmembrane domain M3